[Impaired interferon status in children with acute respiratory infection and its correction with

E A Lykova1, A A Vorob'ev, A G Bokovoĭ

  • 1Central Clinical Hospital of the Head Office of the President of the Russian Federation, Moscow, Russia.

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|September 11, 2001
PubMed

Insights

This study investigated interferon status in children with acute respiratory virus infections (ARVI). Bifidumbacterin forte, a probiotic, was found to positively regulate the interferon system in these patients.

Area of Science:

  • Immunology
  • Pediatrics
  • Microbiology

Background:

  • Acute respiratory virus infections (ARVI) significantly impact the immune system.
  • Interferon status is a key indicator of immune response in viral infections.
  • Vegetovascular dystonia serves as a comparison group for immune system evaluation.

Purpose of the Study:

  • To assess interferon status in hospitalized children with complicated ARVI.
  • To evaluate the regulatory effect of Bifidumbacterin forte on the interferon system.
  • To determine the safety and efficacy of Bifidumbacterin forte for correcting interferon status.

Main Methods:

  • Studied interferon status in 46 hospitalized children (33 with ARVI, 13 controls).
  • Administered high doses of Bifidumbacterin forte (probiotic) to ARVI patients.
  • Monitored changes in alpha-interferon, gamma-interferon, and serum interferon levels.

Main Results:

  • Significant alterations in the interferon system were observed in children with ARVI.
  • Bifidumbacterin forte enhanced alpha- and gamma-interferon induction.
  • Bifidumbacterin forte decreased serum interferon production.
  • The probiotic preparation was well-tolerated in high doses.

Conclusions:

  • Bifidumbacterin forte demonstrates a regulatory effect on the interferon system in pediatric ARVI.
  • High-dose Bifidumbacterin forte can be used to correct interferon status in children with respiratory infections.
  • Probiotic intervention shows promise for immune modulation during viral infections.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: